Sepsis: Etiology, Pathophysiology and Survival
-
Upload
changezkn -
Category
Health & Medicine
-
view
3.318 -
download
0
Transcript of Sepsis: Etiology, Pathophysiology and Survival
Sepsis: Etiology, pathophysiology and survival
Michelle Harkins, MD
Objectives
• Define the spectrum of disease from SIRS to septic shock
• Review the epidemiology and factors that effect the severity of disease
• Outline the pathophysiology of sepsis
• Discuss treatment guidelines for therapy
• Review UNM mortality data with the sepsis protocol
SIRS Definition
• Widespread inflammatory response to a variety of severe clinical insults.
• Clinically recognized by the presence of 2 or more of the following:– Temperature >38C or < 36C– Heart Rate >90– Respiratory Rate > 20 or PaCO2 <32– WBC > 12,000, < 4000 or > 10% immature
forms
Sepsis
• SIRS criteria + evidence of infection, or:– White cells in normally sterile body fluid– Perforated viscus– Radiographic evidence of pneumonia– Syndrome associated with a high risk of
infection
Severe Sepsis• Sepsis criteria + evidence of organ dysfunction,
including:– CV: Systolic BP < 90 mmHg, MAP < 70 mm Hg for at
least 1 hour despite volume resuscitation, or the use of vasopressors.
– Renal: Urine output < 0.5 ml/kg body weight/hr for 1 hour despite volume resuscitation
– Pulmonary: PaO2/FiO2 < 250 if other organ dysfunction present or < 200 if the lung is the only dysfunctional organ.
– Hematologic: Platelet count < 80K or decreased by 50% in 3 days
– Metabolic: pH < 7.3 and plasma lactate > 1.5 x upper normal
Organ System Involvement
• Circulation– Hypotension, increases in microvascular permeability
• Lung– Pulmonary Edema, hypoxemia
• GI tract– Translocation of bacteria, Liver Failure
• Nervous System– Encephalopathy, Critical Illness Polyneuropathy
• Hematologic– DIC, coagulopathy
• Kidney– Acute Tubular Necrosis, renal failure
Sepsis Epidemiology
• “Severe Sepsis” is the leading cause of death in (non coronary) ICU
• Sepsis accounts for 40% ICU expenditures
• Sepsis cases increasing @ 1.5% yearly (750,000)
• Septic Shock is sepsis with hypotension despite fluid resuscitation with perfusion abnormalities.
• Mortality– Sepsis: 30% - 50%
– Septic Shock: 50% - 60%
Natural history of sepsis Prospective study (n=2527)
Syndrome ARF (%) ARDS (%)
Sepsis
1 criteria 9 2
2 criteria 13 3
3 criteria 19 6
Severe sepsis
Culture (+) 23 8
Culture (-) 16 4
Septic shock
Culture (+) 51 18
Culture (-) 38 18
Rangel-Frausto et al JAMA, 1995
Normal Response
• TNF release self-stimulating (autocrine process)• Cytokine levels further increase by release of
inflammatory mediators IL-1, platelet activating factor, IL-2, IL-6, IL-8, IL-10, IFN, eicosanoids.
• Continued activation of PMNs, macrophages (paracrine process).
• Clearing of bacteria, debris then tissue repair.• PMN rolling, adhesion, diapedesis, chemotaxis,
phagocytosis and bacterial killing highly controlled and localized.
• Systemic pro-inflammatory reactions– Endothelial damage, microvascular
dysfunction, impaired tissue oxygenation
• Excessive anti-inflammatory response
• Sepsis: auto-destructive process allowing normal responses to infection/injury to involve normal tissues
Pathogenesis of Sepsis
• Proinflammatory Cytokines– TNF-α and IL-1
• Bacterial Factors• Complement Activation• Cellular Injury• Hypoxia• Direct Cytotoxicity• Apoptosis
Bacterial Factors
• LPS, cell wall components and bacterial products such as Staph enterotoxin, TSS toxin-1
• Candida species, Pseudomonas, Klebsiella, Enterobacter and Serratia are predictors of the clinical parameters associated with shock.
Martin et al, NEJM 2003; 348:1546
Endotoxin
• A lipopolysaccharide found in GN bacterial cell walls
• When infused into humans, mimics sepsis• Activates the complement and coagulation
systems• Septic patients demonstrate endotoxemia
and levels correlate with organ dysfunction
Lipopolysacchride (LPS)
LPS-LBP
Proinflammatory Phase of Sepsis-related Organ Dysfunction
Cellular Events During Gram Negative Bacteremia
LPS binding protein (LBP)
mCD14 TLR4-MD2
NF-kB NF-kB + IkB
NF-kB
Promoters
Cytokines, chemokinesVCAM, ICAM MCP-1, Selectin
TNF-, PAF, INF-, LT/PGs, IL-1, 6,8,12,18
Gram negative bacteremia
Lipopolysaccharide (LPS)
Inducible NO synthase (iNOS)
Reactive oxygen species
Peroxynitrite
Tubular damageSystemic
vasodilation, renal eNOS
Glomerular microthrombi
Oxygen radical scavenger
ACUTE RENAL FAILURE
Cytokines
NO+
SEPSIS AND ENDOTOXEMIA
AVP and Hydrocortisone
Insulin Activated Protein C
Hypotension, Increased Catecholamines and
Pressor Resistance to Norepinephrine and
Angiotensin II
Hyperglycemia Disseminated Intravascular Coagulation
Renal Ischemia
WBC Dysfunction and Inflammation
Glomerular and Vascular
Microthrombosis
Early Resuscitation
Hydrocortisone
ACUTE RENAL FAILURE
Who is at risk for Sepsis?
• Patients with + blood cultures
• Comorbidities causing host-defense depression: AIDS, renal or liver failure, neoplasms
• Middle-aged, elderly
Characteristics that influence outcome
• Lack of febrile response
• Leukopenia
• Offending Organism
• Site of infection
• Nosocomial infections
• Shock and organ dysfunction
What do we have to offer these patients?
• Antibiotics• IV Fluids • Vasoactive agents• Source control
• Steroid therapy (adrenal insufficiency)
• Activated protein C• Ventilatory Strategies• Glycemic control
Failed therapies
• Corticosteroids—high dose methylprednisolone
– Bone et al. NEJM 1987;317:653
• Anti-endotoxin antibodies– Zieglar et al. NEJM 1991;324;429
• TNF antagonists—soluble TNF receptor– Fisher et al. NEJM 1996;334:1697
• Ibuprofen– Bernard et al. NEJM 1997;336:912
Treatment of Sepsis
• Early aggressive fluid resuscitation
• Antibiotics early
• Inotropes for BP support (Dopamine, vasopressin, norepinephrine)
• ? Hydrocortisone for adrenal insufficiency
• Tight glycemic control
• Possibly activated Protein C (Xigris)
Fluid Therapy
• No mortality difference between colloid vs. crystalloid• In severe sepsis patients (N=1218): mortality 35.3%
(NS) vs. 30.7% (alb)… 95% CI .74-1.02 p=0.09
Antibiotics
• Abx within 1 hr hypotension: 79.9% survival• Survival decreased 7.6% with each hour of delay• Mortality increased by 2nd hour post hypotension • Time to initiation of Antibiotics was the single
strongest predictor of outcome
Antibiotics
• Predictors of in hospital mortality: – SOFA scores– Respiratory failure within 24 hrs.– Inadequate Empiric Antimicrobial Therapy
• Independent Variables related to administration of inadequate Abx… – Fungal Infection & previous Abx within the last month
Vasopressor Therapy
Steroids
• Steroids for non-responders reduced mortality 10% without an increase in adverse events
• Repeat studies have not supported routinely testing for relative adrenal insufficiency
Surviving Sepsis Implementation:“Care Bundles”
• 6 Hour Sepsis Bundle1. Measure serum lactate2. Blood cultures prior to Abx3. Broad spectrum Abx (3hrs)4. If hypotensive or lactate>4
Fluid bolus Vasopressors for MAP> 65
5. If persistent BP<65 or Lactate >4 Achieve CVP>8 SVO2 >65
• 24 Hour Bundle1. Steroids as needed
2. APC if indicated
3. Tight glycemic control
4. Maintain plateau pressure <30
Sepsis Resuscitation Bundle • The following steps should be completed as soon as possible (within 6 hours) after
identification of a patient that has a positive SIRS screening • Serum lactate measured • Blood Cultures obtained
Appropriate antibiotics administered • If Lactate >4, SBP<90 or SBP decreased >30 mm Hg (Severe Sepsis): • Give 20 ml/kg IVF bolus and assess need for CVP monitoring• If responsive to fluids
– continue aggressive IVFs as indicated – recheck lactate q 4 hours X 3– consider SAC transfer
• If unresponsive to fluids– Transfer to MICU
• Place arterial and central lines
– Repeat fluid bolus 0.5-1L until CVP 8-12 mm Hg • Apply vasopressors for hypotension not responding to initial fluid resuscitation to
maintain mean arterial pressure > 65 mmHg
Sepsis Pts Mortality IndexOn vs Off protocol - Mort Index
0.000.250.500.751.001.251.501.75
3Q08 4Q08 1Q09 2Q09
Mo
rt In
de
x
Coded w/ sepsis AND on protocolPts coded with sepsis NOT on protocol - hospital widePts coded with sepsis NOT on protocol - DoIM
2Q2009 - only includes April & May discharges
Sepsis Pts Observed MortalityOn vs Off Protocol - Observed Mortality
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
3Q08 4Q08 1Q09 2Q09Coded w/ Sepsis ON protocolCoded w/ sepsis NOT on protocol - Hospital wideCoded w/ sepsis NOT on protocol - DoIM
2Q2009 - only includes April & May discharges